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Dental and periodontal phenotype in sclerostin knockout
mice
Ulrike Kuchler1,2,3,*, Uwe Y Schwarze1,2,4,*, Toni Dobsak1,2,4, Patrick Heimel1,2,4,5, Dieter D Bosshardt3,6,
Michaela Kneissel7 and Reinhard Gruber1,2,8
Sclerostin is a Wnt signalling antagonist that controls bone metabolism. Sclerostin is expressed by osteocytes and cementocytes;
however, its role in the formation of dental structures remains unclear. Here, we analysed themandibles of sclerostin knockout mice to
determine the influence of sclerostin on dental structures and dimensions using histomorphometry and micro-computed tomography
(mCT) imaging. mCT and histomorphometric analyses were performed on the first lower molar and its surrounding structures in mice
lacking a functional sclerostin gene and in wild-type controls. mCT on six animals in each group revealed that the dimension of the basal
bone as well as the coronal and apical part of alveolar part increased in the sclerostin knockout mice. No significant differences were
observed for the tooth and pulp chamber volume. Descriptive histomorphometric analyses of four wild-type and three sclerostin
knockout mice demonstrated an increased width of the cementum and a concomitant moderate decrease in the periodontal space
width. Taken together, these results suggest that the lack of sclerostin mainly alters the bone and cementum phenotypes rather than
producing abnormalities in tooth structures such as dentin.
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INTRODUCTION
Sclerostin, a product of the sclerostin gene, antagonizes Wnt/b-cate-
nin signalling.1–2 Sclerostin is a negative regulator of bone formation
and is mainly secreted by osteocytes.3 Sclerosteosis (MIM 269500), a
rare autosomal recessive disorder, is due to the loss of sclerostin
expression.4 van Buchem Disease (OMIM 239100) is related to the
lack of a distant enhancer element that drives sclerostin expression in
bone.5 Both diseases are characterized by bone overgrowth, including
the overgrowth of the jaw and facial bones. Heterozygous human
carriers with low sclerostin levels have a normal skeletal phenotype
with dense bone.6 Patients with sclerosteosis and van Buchem disease
show partial anodontia, delayed tooth eruption and malocclusion.7
Moreover, van Buchem disease is associated with overgrowth of the
mandibular bone, but produces no obvious changes in cementum
thickness,8 although sclerostin is expressed by cementocytes.9–10
Thus, while important information has been gathered from clinical
studies, the exact role of sclerostin in the formation of teeth and the
surrounding periodontal structures is unclear.
Consistent with the clinical phenotype, mice lacking sclerostin have
a high bone mass phenotype.11–12 Moreover, mice lacking sclerostin
demonstrate accelerated fracture healing.13 These observations have
led to the development of pharmacological strategies to neutralize
sclerostin.14 This approach can prevent bone loss in ovariectomized
rodents,15 a finding supported by a recent clinical pilot study.16 In
addition, blocking sclerostin supports bone repair in preclinical mod-
els17 and implant osseointegration.18 Recently, sclerostin antibodies
were shown to stimulate bone regeneration following experimental
periodontitis.19 Most data on sclerostin are focused on its role in bone
development, regeneration and turnover. However, the involvement
of sclerostin in the development of teeth and their periodontal struc-
tures—consisting of the alveolar bone, the periodontal ligament, the
cementum and the gingiva—has not been studied in this particular
mouse model.
Mouse models have revealed that sclerostin is expressed during
tooth development in preodontoblasts, suggesting a possible role in
dentin formation.20 Another Wnt antagonist, dickkopf-1, is strongly
expressed in preodontoblasts.21 Mice with the conditional stabilisa-
tion of b-catenin in the dental mesenchyme present with aberrantly
increased dentin and cementum thickness.22 The absence of b-catenin
leads to erupted molars lacking roots and thin incisors.23 Taken
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together, these data suggest that Wnt/b-catenin signalling has an
impact on the formation of dental tissues. It is thus reasonable to
suggest that sclerostin has a role in the development of teeth and their
surrounding periodontal structures.
The aim of the study was to generate insights into how the lack of
sclerostin influences dental and periodontal tissues. Here, we exa-
mined brachydont first molars, which show eruption patterns similar
to human teeth, in 4-month-old sclerostin knockout mice and the
corresponding wild-type mice.
MATERIALS AND METHODS
Mice
For this study, the first molars and lower jaws of six female sclerostin
knockout and six wild-type control mice at the age of 4 months were
analysed. Sclerostin knockout mice with a targeted disruption of
the sclerostin coding region have been described previously. Hetero-
zygous Sost KO offspring were backcrossed to C57BL/6 mice and then
interbred to generate homozygous Sost mutant mice.12 All mice were
kept in cages at a temperature of 25 6C with a 12-h light–dark cycle.
Mice were fed a standard rodent diet (3302; Provimi Kliba SA,
Penthalaz, Switzerland) and received water ad libitum. Protocols,
handling and care of the mice conformed to the Swiss federal law
for animal protection under the control of the Basel-Stadt Cantonal
Veterinary Office, Switzerland. We use the terminology proposed by
the 1998 Federative Committee on Anatomical Terminology.
Micro-computed tomography
micro-computed tomography (mCT) was performed by vivaCT75
(SCANCO Medical AG, Bru¨ttisellen, Switzerland). The skulls were
scanned at 70 kV/114 mA with a resolution of 20.5 mm and an integ-
ration time of 300 ms. The measurements were performed using
Definiens Developer XD Version 2.0.0 software (Definiens, Munich,
Germany). The teeth were manually classified using Amira 5.3.0 and
5.4.0 software (Visage Imaging GmbH, Berlin, Germany) followed by
automatic classification of the surrounding bone. Regions of interest
are shown in Figures 1 and 2.
Histology and histomorphometric analysis
Skulls were fixed in 4% buffered formaldehyde and stored in 70%
alcohol. Mandibles were dehydrated in alcohol and embedded in
light-cured resin (Technovit 7200 VLC 1 BPO; Heraeus Kulzer &
Co., Wehrheim, Germany). Mandibles were further processed with
Exakt Cutting and Grinding equipment (Exact Apparatebau, Nor-
derstedt, Germany). Thin-ground sections of the first molar of three
Sost KO and four wild-type mice were prepared along themesial tooth
root canal in the buccolingual direction using the cutting-grinding
technique described by Donath24 and stained according to Levai
Laczko. Thin ground sections of three sclerostin knockouts and four
wild-type controls were subjected to histomorphometric analysis.
Digital pictures were obtained with the Olympus dotSlide 2.4 digital
500 mm
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Figure 1 Regions of interest in the 3D analysis of mCT images of bone parts. 3D
regions are defined and automatically segmented in the Definiens Developer XD
2.0.0. 3D, three-dimensional; mCT, micro-computed tomography.
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Buccal
Mesial
Coronal
Sclerostin -/-
Figure 2 Segmentation of different tissue types in the first molar as used for
measurements in Definiens Developer XD 2.0.0. Tooth-tissue (cementum,
dentin, enamelum) and pulp chamber were manually segmented using the
Amira software, and the periodontal ligament space was automatically segmen-
ted in the Definiens Developer XD 2.0.0. No obvious changes in toothmorphology
or the dimension of the dental pulp are visible, which is also supported by the
statistical analysis.
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virtual microscopy system (Olympus, Tokyo, Japan) with a resolution
of 321.5 nm per pixel.
The regions of interest were manually classified with Adobe
Photoshop (Adobe, San Jose, CA, USA) using false colour staining.
Measurements were performed on enamel, dentin, pulp chamber,
mandibular canal, inferior alveolar nerve, basal body area and man-
dibular porosity. Additionally, the cementum and the alveolar part
were split into anatomical sides (lingual/buccal) and then mea-
sured, as shown in Figure 3. The cementum was measured in two
apical and two coronal regions. The coronal region extended
200 mm in the apical direction from the most coronal point of
the cement on each side. The apical region was measured from
the most apical point of the cement on each side that extended
200 mm in coronal direction, starting at the most apical point of
the tooth root canal (or the dentin on the samples where the pulp
did not intersect in this area). Width measurements were per-
formed by averaging the horizontal extent of each row of pixels
in the corresponding region. The thickness of a region was mea-
sured by dividing its area by its length. The measurement was
performed automatically using a Definiens rule set (Definiens
Developer XD Version 2.0.0; Definiens, Munich, Germany) created
for this purpose. Regions of interest are shown in Figure 3.
Statistics
Student’s t-test was performed for three-dimensional (3D) data (volume,
thickness), correcting for multiple testing using the Benjamini–
Hochberg procedure. P values below 0.05 were considered significant.
Descriptive statistical methods (mean6standard deviation) were
applied to the two-dimensional (2D) data (area, width). All computa-
tions were performed using the R 2.15.1 program (http://www.R-
project.org).
RESULTS
Dental and periodontal phenotypes
Histological analyses showed that the dental and periodontal pheno-
types of the 4-month-old wild-type animals were similar to those of
the sclerostin knockoutmice. The anatomy and dimensions of the first
mandibular molars were similar in the wild-type and knockout mice.
The enamel had a comparable structure and thickness, and enamel-
free areas were detected in both the wild-type and knockout mice. The
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Figure 3 Regions of interest in the 2D analysis of histological thin ground sections. (a, c) Wild-type, (b, d) sclerostin knockoutmice; (a, b) Levai–Laczko staining, (c,
d) segmentation of different tissue types as used for measurements in Definiens Developer XD 2.0.0 and classified in false colour. Thin ground sections of first molars
were prepared along the canal of the mesial tooth root in the buccolingual direction. 2D, two-dimensional.
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dentin consisted of mineralized dentin matrix, dentinal tubules and
predentin lined by odontoblasts. The dentin thickness was similar in
both groups, and no overt differences were observed regarding the
dimensions of the pulp chamber.
As in the wild-type animals, the periodontium (consisting of gingiva,
dental cementum, periodontal ligament and alveolar bone) showed
healthy conditions in the sclerostin knockout mice. In both groups,
acellular cementumwas present in the coronal half of the roots, whereas
cellular cementum prevailed in the apical root portion. In the wild-type
and sclerostin knockout mice, the acellular cementum was free of
cementocytes, whereas the cellular cementum contained many lacunae
filled with cementocytes. Sites with thicker acellular and cellular cemen-
tum were observed in the sclerostin knockout mice. No apparent dif-
ference was observed concerning the periodontal ligament structure
(i.e., blood vessels, fibroblasts and collagen fibres that were inserted into
the cementum and bone). However, in animals with the sclerostin
deletion, the periodontal ligament width was slightly reduced.
The most striking difference was observed in the basal portion of
the mandibular bone. This bone was thicker in sclerostin knockout
mice than in wild-type animals. Similarly, the lingual and buccal
alveolar part showed regions with increased bone thickness in scler-
ostin knockout mice. Structurally, however, the jaw bone and alve-
olar bone did not reveal any overt differences between the wild-type
and knockout mice, e.g., the bone presented with cement lines and
many osteocytes.
Jaw bone in sclerostin knockout mice
The basal mandibular bone in the sclerostin knockoutmice was approxi-
mately twice the size of that of the wild-type animals (volume 1168.9%
and thickness 1105.6%) (Table 1). The coronal and, to a lesser extent,
the apical part of alveolar part were increased following sclerostin dele-
tion (coronal volume 151.2% and thickness 158.4%; apical volume
126.8% and thickness 127.1%). Histomorphometric data support
the mCT data (Figure 4 and Table 2). The histomorphometric analysis
Table 1 Micro-computed tomography data of two groups with six animals each
Parameters
Number Mean
Variety of wild
type/%
Standard deviation
P valueWild tpye Sclerostin Wild tpye Sclerostin Wild tpye Sclerostin
Basal body volume 6 6 2.143108 5.753108 1168.89 2.373107 4.383107 ,0.001
Basal body thickness 6 6 455.03 935.44 1105.58 41.24 112.22 ,0.001
Coronal alveolar part
volume
6 6 5.323107 8.043107 151.20 8.603106 1.373107 0.041
Coronal alveolar part
thickness
6 6 152.85 242.15 158.43 26.24 20.91 0.002
Apical alveolar part volume 6 6 1.193108 1.513108 126.79 8.413106 1.413107 0.017
Apical alveolar part
thickness
6 6 590.39 750.57 127.13 42.03 72.00 0.018
Tooth volume 6 6 1.123109 1.143109 11.15 3.363107 6.893107 1
Pulp chamber volume 6 6 8.623107 7.683107 210.89 6.633106 1.293107 0.72
Groups were compared by two-way analysis of variance on in-transformed data with post hoc multiple t-tests, according to the Benjamin–Hochberg procedure. Values are
given in mm.
Table 2 Histomorphometric data representing four wild type and three SOST knockout animals
Parameters
Number Mean
Variety of wild type/%
Standard deviation
Wild type Sclerostin Wild type Sclerostin Wild tpye Sclerostin
Basal body area 4 3 7.733105 1.873106 1141.72 43 636 1.043105
Basal body width 4 3 500.84 940.42 187.77 26.20 47.45
Alveolar part area 4 3 5.753105 8.213105 142.86 44 778 24692
Alveolar part width 4 3 411.43 550.66 133.84 17.80 20.25
Periodontal space area 4 3 2.843105 2.283105 219.71 19 336 16661
Periodontal space width 4 3 80.317 61.143 223.87 7.34 3.57
Dentine area 4 3 6.273105 6.453105 12.86 53 242 49833
Total cement area 4 3 99 884 1.513105 150.68 16 162 28224
Total cement width 4 3 258.77 327.94 126.73 30.92 40.53
Buccal acellular cement area 4 3 52 111 72729 139.57 10 735 22294
Buccal acellular cement width 4 3 128.14 153.59 119.86 16.27 27.70
Buccal cellular cement area 4 3 1 568 2070 132.01 176.14 202.46
Buccal cellular cement width 4 3 5.09 6.85 134.65 0.63 0.29
Lingual acellular cement area 4 3 42 949 70715 164.65 11 781 16061
Lingual acellular cement width 4 3 117.51 154.59 131.55 23.09 14.01
Lingual cellular cement area 4 3 3 256.42 4 988.80 153.23 638.81 160.06
Lingual cellular cement width 4 3 8.03 12.90 160.71 1.82 1.47
Mandibular porosity area 4 3 1.023105 21 991 278.42 26 601 2643.9
Mandibular canal area 4 3 55 155 61327 111.19 2 327.1 4 496.7
Inferior alveolar nerve area 4 3 17 454 25512 146.17 1 722.4 2 578.7
Pulp chamber area 4 3 2.033105 1.323105 235.06 15 078 35230
A descriptive statistic was performed. Values are given in mm.
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further suggests that the sclerostin deletion reduced the mandibular
porosity (278.4%). The nerve canal area and the inferior alveolar
nerve area were increased (111.2% and 146.2%, respectively).
Together, these results indicate that the sclerostin deletion is respon-
sible for the observed bone increase, and interestingly, this deletion
plays a larger role in the basal body than in the alveolar part.
First molar and the periodontal ligament space in sclerostin
knockout mice
Tooth dimensions, e.g., tooth volume (11.2%) and pulp chamber
(210.9%), were not significantly changed in the sclerostin knockout
animals (Figure 2 and Table 1). The histomorphometric data basically
supported the mCT findings (Table 2). Moreover, the histomorpho-
metric data further showed a tendency towards a smaller periodontal
ligament space (area219.7% and width223.9%) following sclerostin
deletion. These findings suggest that the development of the outer
dimensions of the tooth occur independently of the sclerostin gene,
while there is a trend towards a smaller pulp chamber and periodontal
ligament space.
Cementum in sclerostin knockout mice
Based on the histomorphometric analysis, the sclerostin knockout
caused an increase in lingual acellular cementum (area 153.2% and
width 160.7%) and cellular cementum (area 164.6% and width
131.5%). The increase was visible to a lesser extent in the buccal acellular
cementum (area 139.57% and width 119.86%) and cellular cementum
(area132.0% andwidth134.7%). Thus, the deletion of sclerostin led to
a phenotype characterized by thickened acellular and cellular cementum.
The data are summarized in Table 2 and a representative picture is
shown in Figure 4. Cementum was not evaluated separately in the
mCT imaging. Cementum, dentin and enamel were undistinguishable
in the mCT images and thus, were classified as one tissue, labelled ‘tooth’.
DISCUSSION
The studies described here reveal that (i) sclerostin controls the
dimensions of the mandible, through the basal bone and the tooth-
supporting alveolar part; (ii) sclerostin controls the dimensions of the
cementum and the periodontal space; and (iii) sclerostin affects the
dimensions of the pulp chamber, while the outer dimension of the first
molar was not affected. The effect of the sclerostin on the mandibular
bone and cementum presumably resulted from the ability of sclerostin
to antagonize Wnt signalling. Thus, once the antagonist cannot be
expressed properly, the unlocked Wnt pathway stimulates the prolif-
eration and differentiation of osteoblasts and likely also cementocytes
and odontoblasts.
In accordance with the sclerostin deletion results, the stabilisation of
b-catenin leads to the premature differentiation of odontoblasts and
differentiation of cementoblasts and causes marked dentin and cemen-
tum formation.22 Because the lack of sclerostin also should increase
Wnt/b-catenin signalling, an overlapping phenotype would be expected.
However, b-catenin is not the exclusive Wnt signalling pathway. At least
in bone, b-catenin mutants do not fully mimic the phenotype of recep-
tor and antagonist mutants, although their overall bone mass phenotype
is consistent.25–26 Thus, our description of the dental phenotype of
sclerostin knockout mice complements the existing data on Wnt/b-
catenin in the mineralized tissue related to dentistry.
It is clear from this study that the basal mandibular bone in scler-
ostin knockout mice was approximately doubled in size compared to
Wild type
Sclerostin -/- 500 mm
Figure 4 Close-up of buccal and lingual acellular cement of the wild-type and sclerostin knockout mouse models. The magnification shows the area immediately
below the alveolar crest. The cementum appears reddish in the Levai–Laczko staining. Overall, the deletion of sclerostin led to a phenotype characterised by a
thickened acellular cementum, as reported in Table 2. The arrowhead indicates the position of the apex of the alveolar crest.
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that of the wild-type animals, while the coronal and particularly the
apical part of the alveolar bone showed a lesser increase. These data
basically support previous observations that the sclerostin knockout
caused a more pronounced increase of trabecular structure of
the distal femoral metaphysis, compared to cortical bone of the
femur midshaft.11,26 However, as we have solely focused on cortical
structures, the anatomical gradient was unexpected. The anabolic
effect caused by the blocking of sclerostin most likely depends on
the remaining biomechanical control of the respective anatomical
structures.27–28 Thus, the bones in the skull are heterogeneous, and
it would be worthwhile to further investigate these site-specific
changes to determine which types of bone are sensitive to a lack of
sclerostin signalling.
Acellular cementum is a unique tissue, while cellular cementum and
bone share some similarities.29–30 Thus, the obvious increase in acel-
lular cementum deserves attention. Acellular cementum is formed
during tooth development, not as a consequence of postnatal mod-
elling or remodelling. In accordance with our findings, excessive acel-
lular cementum formation was observed after constitutive b-catenin
stabilisation.22 This supports the role of Wnt/b-catenin signalling in
the formation of the dentoalveolar complex.31 Whether sclerostin is
functionally linked with the control of acellular cementum in phos-
phate metabolism32–33 and mutations of the progressive ankylosis
protein and plasma cell membrane glycoprotein-1 genes34–35 remains
unclear. However, mouse models provide valuable insights into the
biology of the mysterious process of cementogenesis.
Accordingly, mouse models have become increasingly important in
dentistry. Recent studies have reported on the phenotypic changes that
occur upon the selective deletion of BMP4 in osteoblasts and odonto-
blasts.36 Transgenic mice are another useful model system and were
used to show that ameloblastin overexpression induces alveolar bone
loss and tooth root resorption.37 Recently, signalling cascades con-
necting dentin matrix protein 1 and dentin sialophosphoprotein were
studied in rodent models.35 Similar models with sclerostin might con-
firm the recent findings, as Wnt/b-catenin signalling is complex.2
Moreover, mouse models revealing the role of DKK-1, another ant-
agonist of Wnt/b-catenin signalling, on the tooth, the dimension
of the tooth and the periodontium would be worth investigating,
particularly because DKK1 is a negative regulator of normal bone
homeostasis in vivo.38 Taken together, these mouse models show
phenotypes and pathophysiological mechanisms that are of clinical
relevance.
The clinical relevance of the present study is twofold. First, this
study helps us to understand the pathological mechanisms that occur
in tooth development in van Buchem disease or sclerosteosis patients.
In accordance with the clinical picture, there is an overgrowth of not
only the mandible, but also the alveolar bone, which explains the
difficulty of tooth extractions in patients lacking sclerostin.8 Our find-
ings also supplement the radiological observations of the cementum
thickness in van Buchem disease patients.8 Based on our findings, it
appears to be worthwhile to perform further analysis of cementum in
the extracted teeth of patients with van Buchem disease or sclerosteo-
sis. Moreover, it is worthwhile to test the potential of sclerostin-inhib-
iting pharmacological therapies for the promotion of periodontal
regeneration, including new cementum formation after periodontal
treatment and tooth movement.16
The present study has several limitations. First, it focused on the
examination of the mandible, and the maxillae were not examined.
This decision was based on the less complicated preparation of the
histological specimens from the first molar in the mouse mandible.
The preclinical data are presumably also representative for themaxilla,
as patients with sclerosteosis and van Buchem disease are both severely
affected.4–7 Another limitation is that in the present study, the pheno-
type was investigated at one time point, which does not allow any
conclusions on the effect of sclerostin during tooth development.
This time point was chosen because tooth development ceases by 4
months of age in mice.
The results presented here thus suggest that the lack of sclerostin
causes more basal and alveolar bone deposition and supports the
formation of cementum. It will now be important to investigate the
therapeutic relevance of targeting the Wnt/beta-catenin signalling
pathway in three contexts: periodontal regeneration, implant dentistry
and dentin formation.
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